Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blackwell, K.
Right arrow Articles by Greenberg, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blackwell, K.
Right arrow Articles by Greenberg, C.
Journal of Clinical Oncology, Vol 18, Issue 3 (February), 2000: 600
© 2000 American Society for Clinical Oncology

Plasma D-Dimer Levels in Operable Breast Cancer Patients Correlate With Clinical Stage and Axillary Lymph Node Status

By Kimberly Blackwell, Zishan Haroon, Gloria Broadwater, Donald Berry, Lyndsay Harris, J. Dirk Iglehart, Mark Dewhirst, Charles Greenberg

From the Divisions of Medical and Radiation Oncology, Duke University Comprehensive Cancer Center, Durham, NC.

Address reprint requests to Charles Greenberg, MD, Department of Medicine and Pathology, Duke University Medical Center, Durham, NC 27710; email green032{at}mc.duke.edu

PURPOSE: To investigate the relationship between preoperative plasma D-dimer levels and extent of tumor involvement in operable breast cancer patients.

PATIENTS AND METHODS: A total of 140 preoperative plasma specimens were obtained from women scheduled to undergo diagnostic breast biopsies. Ninety-five patients in the initial group went on to undergo axillary lymph node dissection. Of the 140 patients from whom plasma samples were obtained, 102 were subsequently diagnosed with invasive breast carcinoma, nine were subsequently diagnosed with ductal carcinoma-in-situ, and 20 were subsequently diagnosed with benign breast disease. Plasma D-dimer levels were quantitated using a commercially available immunoassay kit (DIMERTEST; American Diagnostica, Greenwich, CT). The relationships between plasma D-dimer and other prognostic variables (tumor size, estrogen receptor, progesterone receptor, nuclear grade, histologic grade, lymphovascular invasion, and clinical stage grouping) were then examined using univariate and multivariate linear and logistic regression analyses.

RESULTS: Median plasma D-dimer levels were significantly higher in patients with invasive carcinoma than those patients with either benign breast disease or carcinoma-in-situ (P = .0001). A significant relationship existed between the presence of elevated D-dimer (> 100 ng/mL) and involved axillary lymph nodes ({chi}2 test; P = .001). Elevated D-dimer levels predicted positive lymph node involvement in both univariate regression (P = .0035) and multivariate linear regression (P = .012) models. In addition, elevated D-dimer levels predicted the presence of lymphovascular invasion in univariate logistic regression (P = .0025) and multivariate logistic regression analysis (P = .0053). Quantitative D-dimer levels were highly correlated with clinical stage grouping (analysis of variance test; P = .002).

CONCLUSION: Plasma D-dimer levels were markers of lymphovascular invasion, clinical stage, and lymph node involvement in operable breast cancer. This correlation suggests that detectable fibrin degradation, as measured by plasma D-dimer, is a clinically important marker for lymphovascular invasion and early tumor metastasis in operable breast cancer.




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
H.-C. Kwon, S. Y. Oh, S. Lee, S.-H. Kim, J. Y. Han, R. Y. Koh, M. C. Kim, and H.-J. Kim
Plasma Levels of Prothrombin Fragment F1+2, D-dimer and Prothrombin Time Correlate with Clinical Stage and Lymph Node Metastasis in Operable Gastric Cancer Patients
Jpn. J. Clin. Oncol., January 1, 2008; 38(1): 2 - 7.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. M. Querol-Ribelles, J. M. Tenias, E. Grau, J. M. Querol-Borras, J. L. Climent, E. Gomez, and I. Martinez
Plasma d-Dimer Levels Correlate With Outcomes in Patients With Community-Acquired Pneumonia
Chest, October 1, 2004; 126(4): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Blackwell, M. W. Dewhirst, V. Liotcheva, S. Snyder, G. Broadwater, R. Bentley, A. Lal, G. Riggins, S. Anderson, J. Vredenburgh, et al.
HER-2 Gene Amplification Correlates with Higher Levels of Angiogenesis and Lower Levels of Hypoxia in Primary Breast Tumors
Clin. Cancer Res., June 15, 2004; 10(12): 4083 - 4088.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Cushman, A. R. Folsom, L. Wang, N. Aleksic, W. D. Rosamond, R. P. Tracy, and S. R. Heckbert
Fibrin fragment D-dimer and the risk of future venous thrombosis
Blood, February 15, 2003; 101(4): 1243 - 1248.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
M. Oya, Y. Akiyama, T. Okuyama, and H. Ishikawa
High Preoperative Plasma D-dimer Level is Associated with Advanced Tumor Stage and Short Survival After Curative Resection in Patients with Colorectal Cancer
Jpn. J. Clin. Oncol., August 1, 2001; 31(8): 388 - 394.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2000 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online